Op-t Llc
Clinical trials sponsored by Op-t Llc, explained in plain language.
-
Can a peptide tame type 1 diabetes?
Disease control CompletedThis trial is testing an investigational drug called OPT101 in adults with type 1 diabetes. The goal is to see if it is safe and how it affects the immune system. Participants will receive multiple doses of the drug, and researchers will monitor for side effects and measure drug …
Phase 1 • Sponsor: Op-T LLC • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
First human test of OPT101 peptide begins
Knowledge-focused CompletedThis early-stage trial tested the safety of a new drug called OPT101 in 14 healthy volunteers. Participants received either OPT101 or a placebo, and researchers monitored for side effects, vital signs, and lab changes. The study was completed and focused only on safety and how th…
Phase 1 • Sponsor: Op-T LLC • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:23 UTC